Acasti Pharma Celebrates Rare Disease Day

Feb 28, 2022

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022

Feb 14, 2022

Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call

Feb 7, 2022

Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

Jan 3, 2022

Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

Dec 2, 2021

Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd

Nov 24, 2021

Acasti Pharma Announces Annual Stock Option Grants

Nov 12, 2021

Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022

Nov 10, 2021

Acasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Call

Nov 4, 2021

Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan

Oct 6, 2021